Imaging technique offers cancer patient screening for nanomedicine therapies

Despite holding out promise for cancer treatments, nanomedicine lacks a means to predict patient response to tumour-targeting therapy. The CONQUEST project has devised imaging which differentiates between those likely to benefit and those unlikely to do so.

A significant barrier for the nanopharmaceutical industry tackling cancer is that while some patients treated with nanomedicine (NM) show major improvements in survival rates and quality of life, many others do not respond well.

Further details: Imaging technique offers cancer patient screening for nanomedicine therapies